MedTrace Logo

Randomized Controlled Trial to Compare Two Anti-scorpion Serums

NCT00739440 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2013-08-07

No results posted yet for this study

Summary

The purpose of this study is to compare the efficiency and safety of the treatment against sting scorpion, using two serums, one elaborated by Birmex versus other commercial serum

Conditions

  • Scorpion Sting

Interventions

BIOLOGICAL

serum antiscorpion

The dose may be required for the patient according to clinical manifestations and evolution

Sponsors & Collaborators

  • Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.

    lead OTHER

Principal Investigators

  • Jimenez C Ma. Eugenia, PhD · Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2008-10-31
Completion
2008-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00739440 on ClinicalTrials.gov